Clinical trial
Treatment of Early Systemic Sclerosis by Bosentan
NCT00226889 · Rikshospitalet University Hospital, Other · Terminated
Key facts
| NCT number | NCT00226889 |
|---|---|
| Title | Treatment of Early Systemic Sclerosis by Bosentan |
| Acronym | TRANOS |
| Lead sponsor | Rikshospitalet University Hospital, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Sclerosis (Scleroderma) |
| Intervention type | Drug |
| Interventions | bosentan |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 27, 2005 |
| Last update posted | Jun 12, 2009 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: